Skip to main content
. 2019 Apr 23;39(4):BSR20182144. doi: 10.1042/BSR20182144

Figure 1. Desipramine treatment inhibits aSMase activity and ceramide accumulation in diabetic mice.

Figure 1

(A) Effect of desipramine on serum aSMase activity (n=10). (B) Effect of desipramine on aortic aSMase activity (n=10). (C) Effect of desipramine on serum ceramide content. (D) Effect of desipramine on aortic ceramide content (n=10). Data are shown as the mean ± S.E.M. with n=10 animals per group. *P<0.05 compared with the NC group. #P<0.05 compared with the DC group.